Gencor Pacific Inc., are pleased to announce that the Caralluma Fimbriata Extract marketed by them under their brand SLIMALUMA has been awarded patents in South Africa and in India.
The South African patent number is 2005 / 9780 and the Indian patent number is 210052. This ensures that all clients of Gencor Pacific in these markets get the benefits of Intellectual Property protection. SLIMALUMA is the original Caralluma Fimbriata Extract which is supported by human clinical studies and extensive toxicity studies validating it's efficacy and safety.
Slimaluma also is protected by US Patent No. 7,060,308. Few more patent applications are pending in USA, Canada and in various International Markets, covering product, processes and uses of the product, giving clients of Gencor a wide range of Intellectual Property Protection.
This re-inforces Gencor’s effort in innovation and development of new functional ingredients for lifestyle management.